PRESS RELEASE published on 10/04/2023 at 21:30, 3 years 1 month ago EQS-Adhoc: EHC convenes EGM to extend business combination deadline and publishes repurchase document relating to redemption of public shares and proposed amendment of Warrant T&C
PRESS RELEASE published on 09/27/2023 at 18:30, 3 years 1 month ago European Healthcare Acquisition & Growth Company B.V. publishes its half-year report 2023
PRESS RELEASE published on 09/20/2023 at 12:30, 3 years 1 month ago EQS-Adhoc: European Healthcare Acquisition & Growth Company B.V. announces intention to extend Business Combination Deadline, to offer redemption of Public Shares and to terminate all Public and Sponsor Warrants
PRESS RELEASE published on 08/07/2023 at 19:00, 3 years 2 months ago EQS-Adhoc: European Healthcare Acquisition & Growth Company B.V. and Croma-Pharma GmbH terminate discussion on business combination
PRESS RELEASE published on 06/27/2023 at 12:55, 3 years 4 months ago General meeting of shareholders of European Healthcare Acquisition & Growth Company B.V. adopts all resolutions
PRESS RELEASE published on 06/26/2023 at 19:15, 3 years 4 months ago EQS-Adhoc: European Healthcare Acquisition & Growth Company B.V. removes shareholders’ votes on proposed business combination with Croma-Pharma GmbH from agenda of general meeting
PRESS RELEASE published on 06/23/2023 at 19:30, 3 years 4 months ago EQS-Adhoc: European Healthcare Acquisition & Growth Company B.V. received redemption notices with respect to EUR 185.85 million – minimum net cash condition is not yet fulfilled
PRESS RELEASE published on 06/21/2023 at 09:43, 3 years 4 months ago EQS-Adhoc: European Healthcare Acquisition & Growth Company B.V.: Public disclosure of inside information
PRESS RELEASE published on 05/16/2023 at 23:15, 3 years 5 months ago European Healthcare Acquisition & Growth Company B.V convenes annual general meeting of shareholders and publishes shareholder circular relating to proposed business combination with Croma-Pharma GmbH
PRESS RELEASE published on 05/16/2023 at 00:45, 3 years 5 months ago EQS-Adhoc: European Healthcare Acquisition & Growth Company B.V. and Croma-Pharma GmbH, agree on adjusted enterprise value of Croma, and Sponsors waive 20% sponsor shares and devalue 20% sponsor warrants
Published on 11/06/2026 at 22:15, 13 hours 41 minutes ago Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 22 hours 56 minutes ago Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 23 hours 26 minutes ago Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 23 hours 26 minutes ago Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/06/2026 at 20:15, 15 hours 41 minutes ago African Medicines Agency Marks First Year of Operations with New Platforms to Strengthen Regulation and Support Manufacturing
Published on 11/06/2026 at 19:15, 16 hours 40 minutes ago EQS-Adhoc: ABO Energy GmbH & Co. KGaA suspends the interest payment on the bond 2024/2029 due on 8 November 2026.
Published on 11/06/2026 at 19:00, 16 hours 56 minutes ago Finexity AG: FINEXITY issues 2026/2030 bond with a minimum of 7.00% p.a. – either conventionally in a securities account or as a crypto security in a wallet
Published on 11/06/2026 at 18:32, 17 hours 23 minutes ago EQS-Adhoc: Finexity AG: FINEXITY issues 2026/2030 bond
Published on 11/06/2026 at 18:00, 17 hours 56 minutes ago ARVERNE GROUP: Number shares and voting rights
Published on 11/06/2026 at 18:00, 17 hours 56 minutes ago DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 11/06/2026 at 17:54, 18 hours 1 minute ago Disclosure of Share Capital and Voting Rights as of October 31, 2026
Published on 11/06/2026 at 17:35, 18 hours 21 minutes ago Disclosure of the number of shares and the total number of voting rights as of October 31, 2026
